SCHEMBL10446504

SCHEMBL10446504

CCc1ncc2cc(C(=O)Nc3cccc(C(=O)OC)c3)c(=O)[nH]c2n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 5/20 0.53
▸ DYRK1B Q9Y463 5/20 0.53
▸ RAB9A P51151 5/20 0.49
▸ ALDH1A1 P00352 4/20 0.46
▸ TDP1 Q9NUW8 2/20 0.46
▸ HPGD P15428 2/20 0.46
▸ NR4A1 P22736 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ TP53 P04637 1/20 0.44
▸ POLB P06746 2/20 0.44
▸ MAPT P10636 2/20 0.44
▸ ABL1 P00519 1/20 0.43
▸ RIN1 Q13671 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ HTT P42858 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ ABCB1 P08183 1/20 0.43
▸ KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10446240 0.90 DYRK1A (0.48) DYRK1ADYRK1BRAB9ASMN1; SMN2TP53
SCHEMBL10446237 0.89 DYRK1A (0.45) DYRK1ADYRK1BALDH1A1L3MBTL1MAPT
SCHEMBL10446629 0.81 DYRK1A (0.45) DYRK1ADYRK1BALDH1A1L3MBTL1POLB
SCHEMBL10321615 0.79 RAB9A (0.50) DYRK1ADYRK1BRAB9AALDH1A1TDP1
SCHEMBL10330656 0.74 GPR17 (0.54) DYRK1ADYRK1BRAB9AALDH1A1TDP1
SCHEMBL10322470 0.74 RAB9A (0.43) DYRK1ADYRK1BRAB9AALDH1A1TDP1
SCHEMBL10323421 0.74 POLB (0.48) DYRK1ADYRK1BRAB9AALDH1A1L3MBTL1
SCHEMBL10322342 0.73 POLB (0.47) DYRK1ADYRK1BRAB9AALDH1A1L3MBTL1
SCHEMBL21639501 0.73 RAB9A (0.51) DYRK1ADYRK1BRAB9AALDH1A1HPGD
SCHEMBL10446512 0.73 KDM4E (0.41) DYRK1ADYRK1BALDH1A1HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120184542-A1 PYRIDO PYRIMIDINES ANDERSON KEVIN (US) 2012-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184542-A1 PYRIDO PYRIMIDINES TYMS, TYMP, DPYD DYRK1A 654/4885DYRK1B 570/4885RAB9A 2086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback